发明名称 VIRALE NUKLEOTIDSEQUENZEN
摘要 <p>A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK<-> or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.</p>
申请公布号 AT422543(T) 申请公布日期 2009.02.15
申请号 AT19990114400T 申请日期 1989.09.13
申请人 MERIAL 发明人 GRIFFIN, ANNETTE MARY;ROSS, LOUIS JOSEPH NORMAN;SCOTT, SIMON DAVID;BINNS, MATTHEW MCKINLEY
分类号 A01K67/027;C12N15/38;A61K31/00;A61K35/76;A61K38/00;A61K39/00;A61K39/215;A61K39/245;A61K39/255;A61K39/265;A61K39/275;A61K39/295;A61K48/00;A61P31/00;A61P31/12;A61P31/20;A61P31/22;A61P37/04;C07K14/03;C07K14/035;C07K14/055;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N7/00;C12N7/01;C12N7/04;C12N9/02;C12N9/12;C12N15/00;C12N15/09;C12N15/45;C12N15/86;C12N15/869;C12P21/02;C12R1/91;C12R1/92 主分类号 A01K67/027
代理机构 代理人
主权项
地址